Clinical trials in Scheemda

Innovative research focusing on genotype-guided antithrombotic treatment for patients with peripheral arterial disease, aiming to reduce adverse clinical events related to arterial thrombosis.

• Arterial Thrombosis Prevention
• Cardiovascular Events Reduction
• Limb Preservation Strategies

Advanced studies targeting improved outcomes in vascular health management.

Groundbreaking research evaluating dose-optimized chemotherapy approaches for elderly patients with metastatic colorectal cancer, alongside innovative treatment protocols for multiple myeloma.

• Colorectal Cancer Treatment
• Multiple Myeloma Management
• Treatment Optimization Studies

Focused on developing personalized treatment strategies for better patient outcomes.

Advanced studies in Multiple Sclerosis treatment optimization, investigating personalized dosing approaches with various therapeutic agents including ocrelizumab and natalizumab.

• Personalized Treatment Protocols
• Extended Interval Dosing
• Disease Activity Management

Exploring innovative approaches to enhance MS treatment effectiveness and patient care.